Pioneering first-in-class therapeutics for endometriosis & uterine diseases
Over two billion patients globally suffer from uterine diseases that originate in the endometrium and surrounding tissues without disease-modifying, targeted therapeutics.
We’re here to change that.
backed by
The endometrium is a uniquely complex human tissue.
Diseases of the endometrium can have debilitating effects that can extend far beyond fertility. Conditions like endometriosis can influence systemic physiology, including immune, cardiovascular, and metabolic pathways.
Endometriosis lacks appropriate model systems as lab rodents don’t naturally menstruate.
As a result, unlike many other diseases of the same magnitude, endometriosis still lacks reliable disease targets and targeted, disease-modifying treatments.
Our platform is designed to change that.
Our mission